Inhibition of muscarinic-stimulated polyphosphoinositide hydrolysis and Ca2+ mobilization in cat iris sphincter smooth muscle cells by cAMP-elevating agents

Cellular Signalling

Volumn 9, Issue 6, 1997, Pages 411-421

  Ding, Ke Hong ^a   Husain, Shahid ^a   Akhtar, Rashid A ^a   Isales, Carlos M ^a   Abdel Latif, Ata A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Carbachol; Cyclic AMP; Intracellular calcium; Iris sphincter smooth muscle cells; Isoproterenol; Phosphoinositide metabolism

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CARBACHOL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; INOSITOL 1,4,5 TRISPHOSPHATE; ISOPRENALINE; MUSCARINIC AGENT; MUSCARINIC M3 RECEPTOR; POLYPHOSPHOINOSITIDE; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CAT; DOSE TIME EFFECT RELATION; HYDROLYSIS; IRIS; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; SPHINCTER PUPILLAE MUSCLE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM; CARBACHOL; CATS; CELL FRACTIONATION; CELL MEMBRANE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRENES; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HYDROLYSIS; INOSITOL 1,4,5-TRISPHOSPHATE; IRIS; ISOPROTERENOL; KINETICS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; MUSCLE, SMOOTH; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C; PHOSPHORYLATION; PYRROLIDINONES; RYANODINE; THAPSIGARGIN;

ANIMALIA; FELIS CATUS;

EID: 0030775060     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(97)00018-1     Document Type: Article

References (37)

1. Rasmussen H., Kelly G. and Douglas J. S. (1990) Am. J. Physiol. 258, L279-L288.
2. De Lanerolle P. and Paul R. J. (1991) Am. J. Physiol. 261, L1-L14.
3. Challis R. A. J. and Boyle J. P. (1994) Airways Smooth Muscle: Biochemical Control of Contraction and Relaxation (Raeburn D. and Giembycz M. A., Eds) pp. 309-327. Birkhauser Verlag, Basel, Switzerland.
4. Abdel-Latif A. A. (1996) Proc. Soc. Exp. Biol. Med. 211, 163-177.
5. Yang C-M., Hsu M-C., Tsao H-L., Chiu C-T., Ong R., Hsieh J. T. and Fan L-W. (1996) Cell Calcium 19, 243-254.
6. Murray R. K. and Kotlikoff M. I. (1991) J. Physiol. 435, 123-144.
7. Felder C. C., Singer-Lahat D. and Mathes C. (1994) Biochem. Pharmacol. 48, 1997-2004.
8. Abdel-Latif A. A. (1991) Cell. Signal. 3, 371-385.
9. Hoiting B. H., Meurs H., Schuiling M., Kuipers R., Elzinga C. R. S. and Zaagsma J. (1996) Br. J. Pharmacol. 117, 419-426.
10. Madison J. M. and Brown J. K. (1988) J. Clin. Invest. 82, 1462-1465.
11. Hall I. P. and Hill S. J. (1988) Br. J. Pharmacol. 95, 1204-1212.
12. Offer G. J., Chilvers E. R. and Nahorski S. R. (1991) Eur. J. Pharmacol. 207, 243-248.
13. Tachado S. D., Akhtar R. A. and Abdel-Latif A. A. (1989) Invest. Ophthalmol. Vis. Sci. 30, 2332-2239.
14. Tachado S. D., Akhtar R. A., Zhou C-J. and Abdel-Latif A. A. (1992) Cell. Signal. 4, 61-75.
15. Ocklind A., Yousufzai S. Y. K., Ghosh S., Coca-Prados M., Stjernschantz J. and Abdel-Latif A. A. (1995) Exp. Eye Res. 61, 535-545.
16. Howe P. H., Akhtar R. A., Naderi S. and Abdel-Latif A. A. (1986) J. Pharmacol. Exp. Ther. 239, 574-583.
17. Husain S. and Abdel-Latif A. A. (1996) Curr. Eye Res. 15, 329-334.
18. Lowry O. H., Rosenbrough N. J., Farr A. L. and Randall R. J. (1951) J. Biol. Chem. 193, 265-275.
19. Zhou C-J., Akhtar R. A. and Abdel-Latif A. A. (1994) Exp. Eye Res. 59, 377-384.
20. Fabiato A. and Fabiato F. (1979) J. Physiol. Paris 75, 463-505.
21. Wang X.-L., Akhtar R. A. and Abdel-Latif A. A. (1995) Biochem. J. 308, 1009-1016.
22. Gasalla-Herraiz J., Rhee S. and Isales C. M. (1995) Biochem. Biophys. Res. Commun. 214, 373-388.
23. Grynkiewicz G., Poenie M. and Tsein R. Y. (1985) J. Biol. Chem. 260, 3440-3450.
24. Berridge M. J. (1993) Nature 361, 315-325.
25. Shima H. and Blaustein M. P. (1992) Circ. Res. 70, 968-977.
26. Fleischer S. and Inui M. (1989) Ann. Rev. Biophys. Chem. 18, 333-364.
27. Bleasdale J. E., Thakur N. R., Gremban R. S., Bundy G. L., Fitzpatrick F. A., Smith R. J. and Bunting S. (1990) J. Pharmacol. Exp. Ther. 255, 756-768.
28. Ohta T., Ito S., Noto T., Tachibana R., Nakazato Y. and Ohga A. (1992) J. Physiol. 453, 367-384.
29. Denning G. M., Clark R. A. and Welsh M. J. (1994) Am. J. Physiol. 267, C776-C784.
30. Mecrez-Lepretre N., Morel J-L. and Mironneau J. (1996) Biochem. Biophys. Res. Commun. 218, 30-34.
31. Low A. M., Gaspar V., Kwan C. Y., Darby P. J., Bourreau J. P. and Daniel E. E. (1991) J. Pharmacol. Exp. Ther. 258, 1105-1113.
32. Sorrentino V. and Volpe P. (1993) Trends Pharmacol. Sci. 14, 98-103.
33. Missiaen L., De Smedt H., Droogmans G., Himpens B. and Casteels R. (1992) Pharmac. Ther. 56, 191-231.
34. Honkanen R. E., Howard E. F. and Abdel-Latif A. A. (1990) Invest. Ophthalmol. Vis. Sci. 31, 590-593.
35. Prestwich S. A. and Bolton T. B. (1995) Brit. J. Pharmacol. 114, 602-611.
36. Murthy K. S., Severi C., Grider J. R. and Makhlouf M. (1993) Am. J. Physiol. 264, G967-G974.
37. Schramm C. M., Chuang S. T. and Grunstein M. M. (1995) Am. J. Physiol. 269, (Lung Cell. Mol. Physiol. 13) L715-L719.